Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01663493 · ClinicalTrials.gov registry record · NA
Comparing Methods to Biopsy Pancreas Mass
A NA study of Pancreas Mass Diagnosis, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
- 1
- Study location
NCT01663493 is a NA study of Pancreas Mass Diagnosis that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 59 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01663493, a NA study of Pancreas Mass Diagnosis, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine whether there is any difference in number of passes needed to diagnose pancreatic masses during endoscopic ultrasound-guided biopsies using 2 different types of needles.
Conditions Studied
Interventions
- PROCEDURE FNB
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01663493
The ClinicalTrials.gov registry entry for NCT01663493 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pancreas Mass Diagnosis appearing as the primary indexed condition, and to 1 intervention - of which FNB is the first listed.
NCT01663493 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01663493 about?
NCT01663493 is a clinical study titled "Comparing Methods to Biopsy Pancreas Mass". This study will examine whether there is any difference in number of passes needed to diagnose pancreatic masses during endoscopic ultrasound-guided biopsies using 2 different types of needles.
What is the current status of trial NCT01663493?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2015-10. Estimated completion is 2017-02.
What conditions does trial NCT01663493 study?
This clinical trial studies the following conditions: Pancreas Mass Diagnosis.
What interventions are being tested in trial NCT01663493?
The interventions under investigation include: FNB (PROCEDURE).
Who is sponsoring clinical trial NCT01663493?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01663493 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.